15.15
Precedente Chiudi:
$14.99
Aprire:
$15.12
Volume 24 ore:
2.86M
Relative Volume:
1.11
Capitalizzazione di mercato:
$3.61B
Reddito:
$510.17M
Utile/perdita netta:
$146.93M
Rapporto P/E:
25.29
EPS:
0.599
Flusso di cassa netto:
$27.51M
1 W Prestazione:
-1.56%
1M Prestazione:
-5.84%
6M Prestazione:
-5.96%
1 anno Prestazione:
-15.41%
Adma Biologics Inc Stock (ADMA) Company Profile
Nome
Adma Biologics Inc
Settore
Industria
Telefono
(201) 478-5552
Indirizzo
C/O ADMA BIOLOGICS, INC., RAMSEY
Compare ADMA vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ADMA
Adma Biologics Inc
|
15.15 | 3.61B | 510.17M | 146.93M | 27.51M | 0.599 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-19 | Ripresa | Raymond James | Strong Buy |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2021-11-11 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Iniziato | Jefferies | Buy |
| 2019-04-15 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-07 | Ripresa | H.C. Wainwright | Buy |
| 2017-12-11 | Reiterato | Maxim Group | Buy |
| 2017-11-14 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Aggiornamento | Maxim Group | Hold → Buy |
| 2016-08-01 | Downgrade | Maxim Group | Buy → Hold |
| 2016-07-25 | Reiterato | Maxim Group | Buy |
| 2015-05-13 | Reiterato | Maxim Group | Buy |
| 2014-12-08 | Iniziato | Oppenheimer | Outperform |
| 2014-12-01 | Reiterato | Maxim Group | Buy |
Mostra tutto
Adma Biologics Inc Borsa (ADMA) Ultime notizie
Reassessing ADMA Biologics (ADMA) After Multi Year Surge And Recent Share Price Pullback - simplywall.st
Why the Market Dipped But Adma Biologics (ADMA) Gained Today - Yahoo Finance
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Best Momentum Stocks to Buy for March 12th - Yahoo Finance Singapore
New Strong Buy Stocks for March 12th - Yahoo Finance Singapore
Price-Driven Insight from (ADMA) for Rule-Based Strategy - Stock Traders Daily
Insider Selling: ADMA Biologics (NASDAQ:ADMA) COO Sells $157,800.48 in Stock - MarketBeat
ADMA (NASDAQ: ADMA) files Form 144 showing RSU vesting and proposed sales - Stock Titan
ADMA (ADMA) CEO uses 85,951 shares to cover RSU tax obligations - Stock Titan
ADMA Biologics (NASDAQ: ADMA) proposes sale of option-exercise shares on 03/09/2026 - Stock Titan
ADMA Biologics (NASDAQ:ADMA) Director Buys $109,690.00 in Stock - MarketBeat
New ADMA Biologics CFO Puts Focus On Margins And Capital Allocation - Yahoo Finance
Returns Recap: Is ADMA Biologics Inc subject to activist investor interestTrade Analysis Report & AI Driven Price Predictions - baoquankhu1.vn
Segall Bryant & Hamill LLC Reduces Stock Position in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Buyback Plan Tests Earnings Story And Valuation Gap - simplywall.st
Legato Capital Management LLC Has $433,000 Holdings in ADMA Biologics Inc $ADMA - MarketBeat
American Century Companies Inc. Purchases 84,934 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Is ADMA Biologics (ADMA) Attractive After Recent Share Price Swings And DCF Upside? - simplywall.st
ADMA Biologics (NASDAQ:ADMA) Upgraded at Zacks Research - MarketBeat
ADMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ADMA Biologics (ADMA) Q4 2025 Earnings Transcript - AOL.com
Adma Biologics (ADMA) Upgraded to Strong Buy: Here's Why - Yahoo Finance
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It? - Finviz
Royce & Associates LP Acquires 292,819 Shares of ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc $ADMA Shares Bought by Rafferty Asset Management LLC - MarketBeat
ADMA Biologics (ADMA) CEO withholds 54,858 shares to cover RSU tax obligations - Stock Titan
ADMA Biologics (ADMA) Announces $200M Capital Return Plan for 20 - GuruFocus
ADMA Biologics Announces $200 Mln Capital Return Plan - Nasdaq
ADMA Biologics Launches Major 2026 Capital Return Plan - TipRanks
ADMA Biologics (NASDAQ: ADMA) recently announced a $125 million accelerated share repurchase agreement with JPMorgan. - Bitget
ADMA Biologics launches $125M accelerated share repurchase as part of ~$200M 2026 buyback plan - TradingView
ADMA Biologics (ADMA) launches $125M accelerated buyback in $200M 2026 plan - Stock Titan
ADMA Biologics commits $125M into rapid buyback, targets $200M in 2026 - Stock Titan
(ADMA) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
ADMA Biologics (ADMA) Valuation After Revenue Growth Guidance Reaffirmation And CFO Transition - simplywall.st
ADMA Biologics (ADMA) Margin Compression Challenges Bullish Growth Narratives Heading Into Earnings - Sahm
Vanguard Group Inc. Sells 388,719 Shares of ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics (NASDAQ:ADMA) Upgraded at Wall Street Zen - MarketBeat
ADMA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
ADMA Biologics (NASDAQ: ADMA) CFO details stock and option holdings - Stock Titan
A Look At ADMA Biologics (ADMA) Valuation After Record Results Guidance And CFO Appointment - Yahoo Finance
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance - Finviz
ADMA Biologics Inc earnings beat by $0.01, revenue fell short of estimates - Investing.com Nigeria
Westfield Capital Management Co. LP Takes $74.87 Million Position in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics CFO Shift Puts Spotlight On Margins And Valuation - simplywall.st
New ADMA Biologics CFO Takes Helm As Valuation Gap Draws Focus - Yahoo Finance
Decoding ADMA Biologics Inc (ADMA): A Strategic SWOT Insight - GuruFocus
ADMA Biologics Inc (ADMA) Q4 2025 Earnings Call Highlights: Stro - GuruFocus
ADMA Biologics (ADMA) Reports Strong 2025 Results and Positive O - GuruFocus
ADMA Biologics Reports Strong Q4 2025 Earnings and Positive Outlook - Intellectia AI
ADMA Biologics Q4 2025 Earnings Call Transcript - MarketBeat
Adma Biologics Inc Azioni (ADMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):